These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7867112)

  • 41. Onset of vecuronium neuromuscular blockade at the hand with an arterio-venous shunt.
    Iwasaki H; Yamauchi M; Narimatsu E; Yamakage M; Tsuchida H; Namiki A
    Can J Anaesth; 1997 Nov; 44(11):1208-10. PubMed ID: 9398964
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reversal of residual neuromuscular block with neostigmine at one to four hours after a single intubating dose of vecuronium.
    Caldwell JE
    Anesth Analg; 1995 Jun; 80(6):1168-74. PubMed ID: 7762847
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A preliminary clinical evaluation of magnetic stimulation of the ulnar nerve for monitoring neuromuscular transmission.
    Iwasaki H; Igarashi M; Namiki A
    Anaesthesia; 1994 Sep; 49(9):814-6. PubMed ID: 7978144
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Edrophonium priming alters the course of neuromuscular recovery from a pipecuronium neuromuscular blockade.
    Naguib M; Abdulatif M
    Can J Anaesth; 1991 Sep; 38(6):722-7. PubMed ID: 1655299
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thenar muscle blood flow and neuromuscular effects of vecuronium in patients receiving balanced or isoflurane anaesthesia.
    Abdulatif M; Hegazy M
    Br J Anaesth; 1994 Jun; 72(6):650-3. PubMed ID: 7912947
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sevoflurane exposure time and the neuromuscular blocking effect of vecuronium.
    Ahmed AA; Kumagai M; Otake T; Kurata Y; Amaki Y
    Can J Anaesth; 1999 May; 46(5 Pt 1):429-32. PubMed ID: 10349921
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Can nicardipine potentiate vecuronium induced neuromuscular blockade?].
    Yamada T; Takino Y
    Masui; 1992 May; 41(5):746-50. PubMed ID: 1351544
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of stabilization on the onset of neuromuscular block when assessed using accelerometry.
    Girling KJ; Mahajan RP
    Anesth Analg; 1996 Jun; 82(6):1257-60. PubMed ID: 8638801
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optimum time for neostigmine administration to antagonize vecuronium-induced neuromuscular blockade.
    Kirkegaard-Nielsen H; Toft P; Severinsen IK; May O
    Eur J Anaesthesiol; 1995 Nov; 12(6):585-9. PubMed ID: 8665881
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of rate of injection on the neuromuscular block produced by vecuronium.
    Feldman SA; Soni N; Kraayenbrink MA
    Anesth Analg; 1989 Nov; 69(5):624-6. PubMed ID: 2572184
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical assessment of neuromuscular blockade produced by vecuronium using twitch, train of four, tetanus and post-tetanic twitch responses of the adductor pollicis muscle.
    Wali FA; Bradshaw EG; Suer AH
    Acta Anaesthesiol Belg; 1988; 39(1):35-42. PubMed ID: 2897150
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adaptive feedback-controlled infusion versus repetitive injections of vecuronium in patients during isoflurane anesthesia.
    Ebeling BJ; Müller W; Tonner P; Olkkola KT; Stoeckel H
    J Clin Anesth; 1991; 3(3):181-5. PubMed ID: 1678941
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Neuromuscular blockade following high-dose vecuronium administration].
    Otagiri T; Nishizawa M; Narita M; Kiyono S
    Masui; 1990 Feb; 39(2):174-83. PubMed ID: 1969971
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mild intraoperative hypothermia does not change the pharmacodynamics (concentration-effect relationship) of vecuronium in humans.
    Heier T; Caldwell JE; Sharma ML; Gruenke LD; Miller RD
    Anesth Analg; 1994 May; 78(5):973-7. PubMed ID: 7909212
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Onset of maximum neuromuscular block following succinylcholine or vecuronium in four age groups.
    Koscielniak-Nielsen ZJ; Bevan JC; Popovic V; Baxter MR; Donati F; Bevan DR
    Anesthesiology; 1993 Aug; 79(2):229-34. PubMed ID: 8102040
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Continuous infusion of vecuronium: the effect of anesthetic agents.
    Cannon JE; Fahey MR; Castagnoli KP; Furuta T; Canfell PC; Sharma M; Miller RD
    Anesthesiology; 1987 Oct; 67(4):503-6. PubMed ID: 2889403
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pipecuronium-induced prolongation of vecuronium neuromuscular block.
    Smith I; White PF
    Br J Anaesth; 1993 Apr; 70(4):446-8. PubMed ID: 8098952
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuromuscular effects of pipecuronium bromide.
    Stanley JC; Mirakhur RK; Bell PF; Sharpe TD; Clarke RS
    Eur J Anaesthesiol; 1991 Mar; 8(2):151-6. PubMed ID: 1651856
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Localized hypothermia influences assessment of recovery from vecuronium neuromuscular blockade.
    Young ML; Hanson CW; Bloom MJ; Savino JS; Muravchick S
    Can J Anaesth; 1994 Dec; 41(12):1172-7. PubMed ID: 7867111
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacodynamics of vecuronium in patients with and without renal failure: a meta-analysis.
    Beauvoir C; Peray P; Daures JP; Peschaud JL; D'Athis F
    Can J Anaesth; 1993 Aug; 40(8):696-702. PubMed ID: 8104726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.